Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation
ACUTE-AF
Feasibility of Examining Acute Responses to Exercise in Symptomatic Females and Males With Atrial Fibrillation: a Pilot Randomized Crossover Study
1 other identifier
interventional
36
1 country
1
Brief Summary
The main purpose of this pilot project is to measure the feasibility of conducting a randomized crossover study examining short-term changes in atrial fibrillation (AF) symptoms in symptomatic females and males with paroxysmal or persistent AF when they engage in a standard week of exercise (i.e. moderate-intensity continuous training \[MICT\] or high-intensity interval training \[HIIT\]) compared to a control week (i.e. no moderate to vigorous exercise over 7 days).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started Feb 2022
Longer than P75 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2021
CompletedFirst Posted
Study publicly available on registry
October 20, 2021
CompletedStudy Start
First participant enrolled
February 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
May 6, 2026
April 1, 2026
5.1 years
September 13, 2021
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Feasibility of the pilot study - Recruitment and consent rate
Through study completion, an average of 1.5 years
Feasibility of the pilot study - Participant fidelity
E.g. ability of participants to comply with the exercise prescription, number of exercise sessions attended
During the week of HIIT and MICT (2 weeks)
Feasibility of the pilot study - Study retention
Dropout rate of participants
Through study completion, an average of 1.5 years
Feasibility of the pilot study - Study eligibility refinement
Data to refine inclusion and exclusion criteria for a larger trial will be used by balancing safety, ability to complete the intervention, and generalizability (e.g. is an exclusion criterion of threshold of participation in \>2 structured exercise sessions/week sufficient or restrictive?)
Through study completion, an average of 1.5 years
Feasibility of the pilot study - Adverse events
Side effects and adverse events during the study
Through study completion, an average of 1.5 years
Secondary Outcomes (2)
AF symptoms self-reported with a 7-day patient symptom questionnaire
3 weeks (1 week of HIIT, 1 week of MICT, 1 week fo rest)
AF status measured daily with a KardiaMobile device
3 weeks (1 week of HIIT, 1 week of MICT, 1 week fo rest)
Study Arms (3)
Moderate Intensity Continuous Training (MICT)
EXPERIMENTALParticipants will do 3 sessions of moderate-intensity continous exercise training over 7 days
High Intensity Interval Training (HIIT)
EXPERIMENTALParticipants will do 3 sessions of high-intensity interval training over 7 days
Rest
NO INTERVENTIONParticipants will abstain from doing moderate- to high-intensity interval training over 7 days
Interventions
Participants will engage in exercise and record AF symptoms prospectively over 7 days
Participants will engage in exercise and record AF symptoms prospectively over 7 days
Eligibility Criteria
You may qualify if:
- Paroxysmal and Persistent AF
- Rate controlled (resting ventricular rate \<110 bpm)
- Able to do a symptom limited exercise test
- At least 40 years of age
- Self-reports being symptomatic in the past 4 weeks
- If female, self-reports being post-menopausal
- Able to read and understand English or French
- Agrees to sign informed consent
You may not qualify if:
- Currently participating in routine exercise training
- Unstable angina or uncontrolled diabetes mellitus; or established diagnosis of severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy with significant obstruction
- Unable to access the Internet or a phone (iPhone and iPad require iOS version 10.0 and up, Android requires version 6.0 and up) during the study period
- Has an automated external defibrillator, an implantable cardioverter defibrillator or other types of pacemaker
- Unwilling or unable to complete the three conditions
- Unable to provide written, informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y4W7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Reed, PhD
Ottawa Heart Institute Research Corporation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2021
First Posted
October 20, 2021
Study Start
February 8, 2022
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
May 6, 2026
Record last verified: 2026-04